OpEx for 2013 – Crystal Ball Predictions

Add bookmark
To look forward we need to first look back.  From 2008-2012 we saw big pharma collide creating larger companies.  Genentech-Roche, Novartis-Alcon, Pfizer-Wyeth and GlaxoSmithKline-Human Genome Sciences just to name a few.  During this same time frame the economies of the world have seen crashes and upheavals causing some of these same companies to “trim” their workforces.  What does all this mean for 2013? Economic worries will hold Operation Excellence in ch...

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended